Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How does B cell depletion therapy work, and how can it be improved?

E A Clark1, J A Ledbetter

  • 1Department of Immunology and National Primate Research Center, Box 357330, University of Washington, Seattle, WA 98195, USA. eclark@bart.rprc.washington.edu

Annals of the Rheumatic Diseases
|October 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Suspension Splint, for Treating Simple and Compound Fractures of the Leg.

Chicago medical examiner·2023
Same author

Report of Surgical Cases Treated at the Battles of Pea Ridge and Prairie Grove, Ark.: Primary and Secondary Amputations, Resections, Exsections, Etc., Etc.

The Chicago medical journal·2023
Same author

A Suspension Splint, Etc.

The Chicago medical journal·2023
Same author

A Suspension Splint, for Treating Simple and Compound Fractures of the Leg.

Buffalo medical and surgical journal·2023
Same author

Method of Treating Fractures of the Olecranon Process, and Head of the Humerus.

Buffalo medical and surgical journal·2023
Same author

A Suspension of Splint, for Treating Simple and Compound Fractures of the Leg.

Atlanta medical and surgical journal·2022

B cell depletion therapy for rheumatoid arthritis likely works through multiple mechanisms, including apoptosis and cytotoxicity, targeting specific B cell subsets. Understanding these pathways can improve treatments for autoimmune diseases.

Area of Science:

  • Immunology
  • Rheumatology
  • Pharmacology

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation.
  • B cell depletion therapy has emerged as a significant treatment modality for RA.
  • The precise mechanisms underlying B cell depletion therapy's efficacy require detailed elucidation.

Purpose of the Study:

  • To outline the potential mechanisms of action for B cell depletion therapy in rheumatoid arthritis.
  • To discuss how different mechanisms contribute to therapeutic outcomes.
  • To explore implications for optimizing B cell depletion strategies in autoimmune diseases.

Main Methods:

  • Review and synthesis of existing literature on B cell depletion mechanisms.
  • Analysis of proposed pathways including CD20-induced apoptosis, complement-dependent cytotoxicity (CDC), and antibody-dependent cell-mediated cytotoxicity (ADCC).

Related Experiment Videos

  • Consideration of selective B cell subset targeting.

    • Main Results:

    • B cell depletion therapy likely involves multiple mechanisms, not a single pathway.
    • Mechanisms such as CD20-induced apoptosis, CDC, and ADCC contribute to B cell reduction.
    • The relative importance of each mechanism may vary depending on the targeted B cell population.

    Conclusions:

    • Multiple mechanisms contribute to the efficacy of B cell depletion therapy in rheumatoid arthritis.
    • Further understanding of these pathways can guide the development of improved therapeutic strategies.
    • These insights are relevant for enhancing treatments for rheumatoid arthritis and other autoimmune conditions.